BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7284273)

  • 1. Ingram method: the precursor of photochemotherapy.
    Raab WP
    Br J Dermatol; 1981 Aug; 105 Suppl 20():77-81. PubMed ID: 7284273
    [No Abstract]   [Full Text] [Related]  

  • 2. Dithranol (anthralin) versus triacetoxyanthracene. Investigations in vitro.
    Raab W
    Br J Dermatol; 1976 Aug; 95(2):193-6. PubMed ID: 782506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of anthralin (dithranol) on mitochondria.
    Morlière P; Dubertret L; Sa e Melo T; Salet C; Fosse M; Santus R
    Br J Dermatol; 1985 May; 112(5):509-15. PubMed ID: 4005152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin polyamine levels in psoriasis: the effect of dithranol therapy.
    Bohlen P; Grove J; Beya MF; Koch-Weser J; Henry MH; Grosshans E
    Eur J Clin Invest; 1978 Aug; 8(4):215-8. PubMed ID: 100325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Glucose-6-phosphate dehydrogenase and topical antipsoriatics. A comparison of anthralin, anthralin-monoacetate, anthralin-diacetate, anthralin-triacetate and 6-hydroxy-2-oxobenzoxathiole (author's transl)].
    Raab W; Siber H
    Arch Dermatol Forsch; 1974; 249(2):179-89. PubMed ID: 4418435
    [No Abstract]   [Full Text] [Related]  

  • 6. Anthralin: chemical instability and glucose-6-phosphate dehydrogenase inhibition.
    Cavey D; Caron JC; Shroot B
    J Pharm Sci; 1982 Sep; 71(9):980-3. PubMed ID: 7131282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anthralin: chemical instability and glucose-6-phosphate dehydrogenase inhibition.
    Cavey D; Caron JC; Shroot B
    Br J Dermatol; 1981 Aug; 105 Suppl 20():15-9. PubMed ID: 7284258
    [No Abstract]   [Full Text] [Related]  

  • 8. Antipsoriatic drug action of anthralin: oxidation reactions with peroxidizing lipids.
    Ducret F; Lambelet P; Löliger J; Savoy MC
    J Free Radic Biol Med; 1985; 1(4):301-6. PubMed ID: 3836247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of ultraviolet light, various temperatures, and zinc ions on anthralin (dithranol). Biochemical and chemical investigations.
    Raab WP; Gmeiner BM
    Dermatologica; 1975; 150(5):267-76. PubMed ID: 1183690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anthralin: historical and current perspectives.
    Ashton RE; Andre P; Lowe NJ; Whitefield M
    J Am Acad Dermatol; 1983 Aug; 9(2):173-92. PubMed ID: 6309924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of anthralin and analogues on growth and [3H] thymidine incorporation in human skin fibroblasts.
    Jacques Y; Reichert U
    Br J Dermatol; 1981 Aug; 105 Suppl 20():45-8. PubMed ID: 7284264
    [No Abstract]   [Full Text] [Related]  

  • 12. An investigation of the ability of antipsoriatic drugs to inhibit calmodulin activity: a possible mode of action of dithranol (anthralin).
    Tucker WF; MacNeil S; Dawson RA; Tomlinson S; Bleehen SS
    J Invest Dermatol; 1986 Aug; 87(2):232-5. PubMed ID: 3016102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial: anthralin--the challenge.
    Shroot B; Schaefer H; Juhlin L; Greaves MW
    Br J Dermatol; 1981 Aug; 105 Suppl 20():3-5. PubMed ID: 7284261
    [No Abstract]   [Full Text] [Related]  

  • 14. Calorimetric and manometric measurements on human skin fibroblasts in culture.
    Pätel M; Schaarschmidt B; Reichert U
    Br J Dermatol; 1981 Aug; 105 Suppl 20():60-1. PubMed ID: 7284268
    [No Abstract]   [Full Text] [Related]  

  • 15. [Senecioyldithranol and beta-carbethoxypropionyldithranol: synthesis and glucose-6-phosphate dehydrogenase inhibition of two new 10-acyl derivatives of the antipsoriatic, dithranol].
    Rychener M; Steiger W; Krebs A
    Pharm Acta Helv; 1988; 63(4-5):111-6. PubMed ID: 3222264
    [No Abstract]   [Full Text] [Related]  

  • 16. [Study on the mode of action of dithranol: increased lipid peroxidation and enzyme inhibition].
    Diezel W; Meffert H; Sönnichsen N
    Dermatologica; 1975; 150(3):154-62. PubMed ID: 125665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anthralin cytotoxicity.
    Dykes PJ; Roberts GP; Marks R
    Br J Dermatol; 1981 Aug; 105 Suppl 20():43-4. PubMed ID: 7284263
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro evaluation of methotrexate and azathioprine for antipsoriatic activity.
    Raab W; Gmeiner B
    Arch Dermatol Res (1975); 1975 Aug; 253(1):77-84. PubMed ID: 1190831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Free radicals and the treatment of psoriasis with special reference to dithranol.
    Mustakallio KK; Martinmaa J; Vilvala R; Halmekoski J
    Med Biol; 1984; 62(2):155-8. PubMed ID: 6471937
    [No Abstract]   [Full Text] [Related]  

  • 20. [Disappearance of psoriactic lesions under the effect of anthralin].
    Chowaniec O
    Przegl Dermatol; 1976; 63(5):665-71. PubMed ID: 1005760
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.